Reduced levels of p15INK4b, p16INK4a, p21cip1 and p27kip1 in pancreatic carcinoma

Li,Gang; Ji,Yuan; Liu,Chen; Li,JingQi; Zhou,YingQi

doi:10.3892/mmr.2012.771

April 2012 Volume 5 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April 2012 Volume 5 Issue 4

Full Size Image

Article

Reduced levels of p15INK4b, p16INK4a, p21cip1 and p27kip1 in pancreatic carcinoma

Authors:
- Gang Li
- Yuan Ji
- Chen Liu
- JingQi Li
- YingQi Zhou
View Affiliations / Copyright

Affiliations: The Third General Surgery Department, Zhanghai Hospital, Second Military Medical University, Shanghai, P.R. China, Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, P.R. China, Laboratory of Cancer Research, Tongji University School of Medicine, Shanghai, P.R. China
Pages: 1106-1110
|
Published online on: January 30, 2012

https://doi.org/10.3892/mmr.2012.771
Expand metrics +

Abstract

Pancreatic carcinoma is one of the leading causes of cancer mortality worldwide, although the molecular mechanisms of this disease are poorly understood. The aim of this study was to examine the expression of cyclin-dependent kinase inhibitors (CDKIs) and the epigenetic modifications in the promoters of these genes. We also evaluated the correlation between the methylation status of CDKI genes and smoking habit in clinical pancreatic carcinoma specimens. Western blotting and real-time PCR were performed to assess CDKI expression. Methylation-specific PCR was carried out to examine the methylation status of the promoters of CDKI genes. In this study, we revealed that reduced levels of the CDKI proteins, p15INK4b, p16INK4a, p21cip1 and p27kip1, are a prominent feature of pancreatic carcinoma patients. The DNA hypermethylation of the promoter was observed in 40% (2 of 5) of the p15INK4b genes, 60% (3 of 5) of the p16INK4a genes and 60% of the p21cip1 genes, which markedly correlated with their decreased mRNA expression. No hypermethylation was detected in the p27kip1 gene promoter in 5 pancreatic carcinoma patients with markedly decreased expression of p27kip1 mRNA, suggesting an alternative mechanism of p27kip in these patients. In this study, patients with a smoking habit displayed methylation of 2 CDKI genes in their pancreatic carcinoma specimens. We concluded that epigenetic modification via hypermethylation represents a critical mechanism for the inactivation of CDKI genes in pancreatic carcinoma.

View Figures

View References

1	P GhadirianHT LynchD KrewskiEpidemiology of pancreatic cancer: an overviewCancer Detect Prev278793200310.1016/S0361-090X(03)00002-312670518
2	AF HezelAC KimmelmanBZ StangerN BardeesyRA DepinhoGenetics and biology of pancreatic ductal adenocarcinomaGenes Dev2012181249200610.1101/gad.141560616702400
3	A JemalR SiegelE WardCancer statisticsCA Cancer J Clin5871962008
4	SJ ElledgeJ WinstonJW HarperA question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesisTrends Cell Biol6388392199610.1016/0962-8924(96)10030-115157521
5	JW HarperGR AdamiN WeiK KeyomarsiSJ ElledgeThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell75805816199310.1016/0092-8674(93)90499-G8242751
6	JJ TangC ShenYJ LuRequirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activationMol Cell Biochem291139144200610.1007/s11010-006-9206-716909308
7	Y LuN YamagishiT YagiH TakebeMutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cellsOncogene16705712199810.1038/sj.onc.12015859488034
8	M SerranoGJ HannonD BeachA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature366704707199310.1038/366704a08259215
9	CJ SherrJM RobertsCDK inhibitors: positive and negative regulators of G1-phase progressionGenes Dev1315011512199910.1101/gad.13.12.150110385618
10	P HainautT SoussiB ShomerDatabase of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospectsNucleic Acids Res25151157199710.1093/nar/25.1.1519016527
11	M HallG PetersGenetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancerAdv Cancer Res6867108199610.1016/S0065-230X(08)60352-88712071
12	F PerroneS TabanoF Colombop15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumorsClin Cancer Res941324138200314519636
13	B KlumpCJ HsiehO NehlsMethylation status of p14ARF and p16INK4a as detected in pancreatic secretionsBr J Cancer88217222200310.1038/sj.bjc.660073412610506
14	Y KuriharaK EgawaS KunimotoT TakeuchiK NoseInduction of p16/INK4a gene expression and cellular senescence by toyocamycinBio Pharm Bull2512721276200210.1248/bpb.25.127212392077
15	B CenH LiIB WeinsteinHistidine triad nucleotide-binding protein 1 up-regulates cellular levels of p27KIP1 by targeting ScfSKP2 ubiquitin ligase and SrcJ Biol Chem28452655276200919112177
16	AB WestG KapatosC O'FarrellN-myc regulates parkin expressionJ Biol Chem2792889628902200415078880
17	JG HermanJR GraffS MyöhänenBD NelkinSB BaylinMethylation-specific PCR: a novel PCR assay for methylation status of CpG islandsProc Natl Acad Sci USA939821982619968790415
18	K BrakensiekF LängerH KreipeU LehmannAbsence of p21CIP1, p27KIP1 and p57KIP2 methylation in MDS and AMLLeuk Res2913571360200515936816
19	G SchneiderRM SchmidGenetic alterations in pancreatic carcinomaMol Cancer2215200310.1186/1476-4598-2-15
20	H WuY ChenZY WangInvolvement of p21 (waf1) in merlin deficient sporadic vestibular schwannomasNeuroscience170149155201020600642
21	Y JiSL MaYP ZhangA combined treatment TNF-α/Gefitinib alleviates the resistance to Gefitinib in PC-9 cells with acquired resistance to GefitinibAnticancer Drug208328372009
22	Z WangY LuJ TangH WangH WuThe phosphorylation status of merlin in sporadic vestibular SchwannomasMol Cell Biochem324201206200919142715

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Reduced levels of p15INK4b, p16INK4a, p21cip1 and p27kip1 in pancreatic carcinoma

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles